IRIS BIOTECHNOLOGIES INC 4
4 · IRIS BIOTECHNOLOGIES INC · Filed Dec 2, 2016
Insider Transaction Report
Form 4
Chin Simon
DirectorChief Executive Officer10% Owner
Transactions
- Sale
Common Stock
2016-11-30$0.11/sh−2,500$285→ 12,731,813 total - Sale
Common Stock
2016-11-22$0.15/sh−1,250$190→ 12,823,594 total - Sale
Common Stock
2016-11-22$0.12/sh−21,750$2,610→ 12,801,844 total - Sale
Common Stock
2016-11-22$0.11/sh−10,000$1,100→ 12,786,194 total - Sale
Common Stock
2016-11-30$0.09/sh−10,000$900→ 12,721,813 total - Sale
Common Stock
2016-11-28$0.08/sh−11,881$950→ 12,744,313 total - Sale
Common Stock
2016-11-22$0.11/sh−5,650$631→ 12,796,194 total - Sale
Common Stock
2016-11-28$0.10/sh−27,500$2,750→ 12,756,194 total - Sale
Common Stock
2016-12-01$0.09/sh−10,000$900→ 12,701,813 total - Sale
Common Stock
2016-11-28$0.12/sh−2,500$300→ 12,783,694 total - Sale
Common Stock
2016-11-29$0.09/sh−10,000$910→ 12,734,313 total - Sale
Common Stock
2016-12-02$0.10/sh−1,250$123→ 12,700,563 total - Sale
Common Stock
2016-12-01$0.11/sh−10,000$1,140→ 12,711,813 total - Sale
Common Stock
2016-12-02$0.08/sh−20,000$1,600→ 12,680,563 total